Denali Therapeutics Inc.
DNLI | NASDAQ
$21.36
+$0.89 (+4.35%)
Sep 22, 2026, 1:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -256M | -128.45M | -128.55M | -126.9M | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M | -84.59M | -60.69M | -70.04M |
Depreciation & Amortization | 6.41M | 3.76M | 3.78M | 2.95M | 3.05M | 3.21M | 1.85M | 1.84M | 1.94M | 2.16M | 2.18M | 2.22M | 1.36M | 10.05M | 3.23M | 1.28M | 1.23M | 1.3M | 1.31M | 1.41M | 1.48M | 1.42M |
Stock-Based Compensation | 46M | 23.09M | 23.95M | n/a | n/a | 25.16M | 25.08M | n/a | 25.1M | 27.84M | 25.99M | 27.46M | n/a | 28.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -19.19M | -31.37M | 8.42M | -2.15M | 20.69M | -19.29M | 9.27M | 34.72M | -12.05M | -16.45M | 7.93M | -447K | -317.72M | 17.88M | 2.37M | 19.14M | -10.61M | -37.21M | -15.98M | 17.31M | -21.02M | -4.43M |
Other Non-Cash Items | -1.47M | -2.11M | -2.74M | 22.88M | 22.49M | -4.94M | -6.45M | 15.86M | -11.08M | -26.01M | -13.2M | -13.28M | 15.04M | -8.73M | 22.13M | 23.94M | 24.43M | 27.77M | 24.52M | 23.66M | 23.63M | 22.19M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -23.15M | -27.5M | 5.02M | -6.22M | 23.29M | -21.93M | 10.56M | 30.35M | -8.16M | -15.81M | 5.85M | -4.41M | -312.95M | 21.58M | 655K | 21.04M | -9.77M | -35.96M | -16.06M | 18.09M | -18.64M | -3.8M |
Operating Cash Flow | -228.21M | -131.2M | -98.54M | -107.3M | -75.3M | -131.47M | -83.72M | -59.14M | -91.22M | -113.62M | -98.66M | -87.36M | -113.17M | -58.8M | -72.66M | -57.05M | -42.9M | -72.11M | -65.49M | -41.43M | -54.22M | -50.24M |
Capital Expenditures | -3.27M | -2.47M | -1.52M | 1.38M | -4.28M | -5.08M | -5.09M | -3.88M | -4.79M | -2.15M | -2.24M | -2.07M | -5.85M | -2.79M | -4.85M | -6.05M | -2.89M | -4.04M | -3.05M | -1.88M | -772K | -2.8M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -423.38M | -123.07M | -252.71M | -50.63M | n/a | -137.93M | -173.7M | -100.46M | -121.65M | -834.16M | -413.72M | -498.14M | -378.13M | -523.71M | -486.71M | -122.87M | -141.12M | -364.34M | -231.45M | -344.2M | -384.19M | -463.11M |
Sales Maturities Of Investments | 417.03M | 220M | 275M | 107.08M | 162.21M | 161.75M | 351M | 198M | 225M | 383.12M | 489M | 601.12M | 552.04M | 433.79M | 364M | 144.34M | 232.65M | 250.5M | 193.75M | 293.06M | 482.5M | 440.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -9.62M | 94.46M | 20.77M | 57.83M | 157.94M | 18.75M | 172.21M | 93.66M | 98.57M | -453.19M | 73.05M | 100.91M | 168.07M | -92.72M | -127.56M | 15.42M | 88.63M | -117.88M | -40.75M | -53.01M | 97.54M | -25.41M |
Debt Repayment | n/a | -17K | -16K | -1.36M | -2.43M | -4.36M | -8.32M | -24.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 199.96M | 200M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 234.03M | 219.04M | 192.13M | -778K | 1.62M | -3.76M | -4.17M | -18.56M | 6.76M | 500.28M | 4.71M | 2.49M | 9.02M | 1.6M | 299.65M | 5.15M | 4.4M | 1.46M | 5.17M | 3.32M | 7.04M | 3.82M |
Net Cash Flow | -3.8M | 182.3M | 114.36M | -50.24M | 84.26M | -116.48M | 84.32M | 15.96M | 14.11M | -66.53M | -20.91M | 16.04M | 63.84M | -149.91M | 99.43M | -36.47M | 50.14M | -188.52M | -101.08M | -91.13M | 50.36M | -71.82M |
Free Cash Flow | -231.48M | -133.67M | -100.06M | -105.92M | -79.58M | -136.55M | -88.81M | -63.02M | -96.01M | -115.77M | -100.89M | -89.43M | -119.02M | -61.59M | -77.51M | -63.1M | -45.79M | -76.15M | -68.55M | -43.31M | -54.99M | -53.04M |
Adj. Free Cash Flow | -277.48M | -156.76M | -124.01M | -105.92M | -79.58M | -161.71M | -113.89M | -63.02M | -121.11M | -143.61M | -126.88M | -116.89M | -119.02M | -89.67M | -77.51M | -63.1M | -45.79M | -76.15M | -68.55M | -43.31M | -54.99M | -53.04M |
Maintenance CapEx | -3.27M | -2.47M | -1.52M | 1.38M | -4.28M | -5.08M | -5.09M | -3.88M | -4.79M | -2.15M | -2.24M | -2.07M | n/a | -2.79M | -4.85M | -6.05M | n/a | n/a | -3.05M | -1.88M | n/a | -543.24K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.85M | n/a | n/a | n/a | -2.89M | -4.04M | n/a | n/a | -772K | -2.26M |
Owner Earnings | -231.48M | -133.67M | -100.06M | -105.92M | -79.58M | -136.55M | -88.81M | -63.02M | -96.01M | -115.77M | -100.89M | -89.43M | -113.17M | -61.59M | -77.51M | -63.1M | -42.9M | -72.11M | -68.55M | -43.31M | -54.22M | -50.78M |
Add to Watchlist
Select watchlists to add or remove DNLI